These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Danilov SM; Gavrilyuk VD; Franke FE; Pauls K; Harshaw DW; McDonald TD; Miletich DJ; Muzykantov VR Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1335-47. PubMed ID: 11350815 [TBL] [Abstract][Full Text] [Related]
12. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Muzykantov VR; Christofidou-Solomidou M; Balyasnikova I; Harshaw DW; Schultz L; Fisher AB; Albelda SM Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2379-84. PubMed ID: 10051650 [TBL] [Abstract][Full Text] [Related]
13. Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. Han J; Shuvaev VV; Davies PF; Eckmann DM; Muro S; Muzykantov VR J Control Release; 2015 Jul; 210():39-47. PubMed ID: 25966362 [TBL] [Abstract][Full Text] [Related]
14. Immunotargeting of glucose oxidase: intracellular production of H(2)O(2) and endothelial oxidative stress. Gow AJ; Branco F; Christofidou-Solomidou M; Black-Schultz L; Albelda SM; Muzykantov VR Am J Physiol; 1999 Aug; 277(2):L271-81. PubMed ID: 10444521 [TBL] [Abstract][Full Text] [Related]
15. RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1. Garnacho C; Shuvaev V; Thomas A; McKenna L; Sun J; Koval M; Albelda S; Muzykantov V; Muro S Blood; 2008 Mar; 111(6):3024-33. PubMed ID: 18182571 [TBL] [Abstract][Full Text] [Related]
16. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes. Papademetriou I; Tsinas Z; Hsu J; Muro S J Control Release; 2014 Aug; 188():87-98. PubMed ID: 24933603 [TBL] [Abstract][Full Text] [Related]
17. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration. Liu G; Place AT; Chen Z; Brovkovych VM; Vogel SM; Muller WA; Skidgel RA; Malik AB; Minshall RD Blood; 2012 Aug; 120(9):1942-52. PubMed ID: 22806890 [TBL] [Abstract][Full Text] [Related]
18. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates. Shuvaev VV; Tliba S; Pick J; Arguiri E; Christofidou-Solomidou M; Albelda SM; Muzykantov VR J Control Release; 2011 Feb; 149(3):236-41. PubMed ID: 21044652 [TBL] [Abstract][Full Text] [Related]
19. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery. Dan M; Cochran DB; Yokel RA; Dziubla TD PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373 [TBL] [Abstract][Full Text] [Related]
20. Binding properties and inhibition of platelet aggregation by a monoclonal antibody to CD31 (PECAM-1). Wu XW; Lian EC Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3154-8. PubMed ID: 9409305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]